Women’s perspectives on the quality of abortion care in Britain
This study is being undertaken by the BPAS research department. The objective is to better understand the perceptions, experiences and opinions of quality of care in women who have sought abortion care in Britain. It aims to invite 24 women who have had an abortion at BPAS in the last 6 months from nine clinics (Streatham, Birmingham South, Doncaster, Newcastle, Middlesbrough, South Shields, Brighton, Cardiff, Bournemouth) in the BPAS clinic network to participate in an in depth interview lasting approximately 45 – 60 mins (in person or remotely via phone or video chat). A payment of £20 per interview will be given to participants for their time and expenses. The results of this study will be used to create a simple tool that can be validated for use in assessing and improving quality of services.
To find out more about the study, contact the research team on 0345 365 5050 ext 330 or email email@example.com
Efficacy of a low-sensitivity urine pregnancy test (LSPT) for identifying ongoing pregnancy after medical abortion at 64 to 70 days of gestation.
This study is being undertaken by the BPAS research department. Medical abortion with mifepristone and misoprostol is safe and highly effective through 70 days gestation. However failed treatments do occur therefore it is important to identify ongoing pregnancies promptly and accurately so that they can be managed appropriately. The optimal mode of follow-up after early medical abortion is still being determined and investigators have looked at innovative ways to ensure that the abortion has been successful while reducing the burden of multiple clinic visits on women. This research aims to compare sensitivity and specificity of LSPT to ultrasound for the detection of ongoing pregnancy (defined as presence of a fetal pole with cardiac activity on ultrasound) following medical abortion in women 64-70 days gestation. Approximately 1500 women will be asked to participate, the results of which may help assess and influence BPAS’ own model of care with regard to medical abortion follow-up from 64- 70 days of gestation as well as the wider community of abortion providers.